Can a bone drug prevent spine surgery failures?
NCT ID NCT07587775
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study looks at whether a drug called abaloparatide can improve bone quality in people with osteoporosis who need spine surgery. About 60 participants will take the drug for 3-6 months before and after surgery. The goal is to see if it reduces complications like broken hardware or new spine problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUMBAR DEGENERATIVE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University at Buffalo Neurosurgery
Buffalo, New York, 14203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Belly fat vs. body mass index: which better predicts spine surgery risks?
- Disc replacement may keep patients working longer than spinal fusion
- Back pain breakthrough? study pits two key surgeries against each other
- Spine surgery showdown: which cage helps bones fuse better?
- Pre-Surgery boot camp for seniors: could exercise and nutrition boost spine surgery recovery?
- Dye test helps spine surgeons see if They've cleaned enough